Elevated levels of aquaporin-4-containing extracellular vesicles in cerebrospinal fluid of patients with bipolar disorder
Abstract
Objectives: To examine a hypothetical dysfunction of the brain water channels in bipolar disorder by analyzing aquaporin-4 (AQP4) exposing extracellular vesicles (EVs) in cerebrospinal fluid (CSF) from individuals with bipolar disorder types 1 and 2, and healthy controls.
Methods: We analyzed exposure of AQP4 EVs to three different epitopes – the N- and C-terminals, and the epitope containing amino acids 273–291 – in CSF by flow cytometry in 24 individuals with bipolar disorder (type 1, n = 20; type 2, n = 4) and in 14 healthy controls.
Results: We observed significantly higher levels of EVs expressing AQP4 in the CSF from individuals with bipolar disorder compared with healthy controls. Specifically, the mean ± SD concentration of AQP4 + EVs per μl CSF for the N-terminal epitope was 346 ± 22 in patients with bipolar disorder type 1, 386 ± 78 in those with bipolar disorder type 2, compared with 39 ± 6.9 in the healthy control group (P < 0.0001). For AQP4+ EVs targeting the C-terminal epitope, the corresponding values were 350 ± 22 for bipolar disorder type 1, 374 ± 46 for bipolar disorder type 2, and 36 ± 6.3 for healthy controls. Similarly, EVs expressing AQP4+ epitopes containing amino acids 273–291 showed concentrations of 344 ± 17 in bipolar disorder type 1, 398 ± 63 in bipolar disorder type 2, and 38 ± 6.4 in the control group (P < 0.0001).
Conclusion: Our findings revealed significantly more EVs expressing the three AQP4 epitopes in patients with bipolar disorder compared with healthy controls. This suggests a dysregulated expression of AQP4, implicating a potential disruption in brain water homeostasis as a contributing pathogenic mechanism in bipolar disorder.
Downloads
References
2. Ueda R, Yamagata B, Niida R, Hirano J, Niida A, Yamamoto Y, Mimura M. Glymphatic system dysfunction in mood disorders: evaluation by diffusion magnetic resonance imaging. Neuroscience. 2024;555:69–75. doi: 10.1016/j.neuroscience.2024.07.026
3. Båve U, Nybom R, Landén M, Wetterberg L. Micrometer-sized thread-like and/or spherical particles in the first fraction of cerebrospinal fluid in patients with bipolar disorder. Bipolar Disord. 2010;12(3):298–305. doi: 10.1111/j.1399-5618.2010.00805.x
4. Nagelhus EA, Ottersen OP. Physiological roles of aquaporin-4 in brain. Physiol Rev. 2013;93(4):1543–62. doi: 10.1152/physrev.00011.201
5. Bejerot S, Hesselmark E, Mobarrez F, Wallén H, Hietala MA, Nybom R, et al. Neuromyelitis optica spectrum disorder with increased aquaporin-4 extracellular vesicles (EVs) prior to autoantibodies in cerebrospinal fluid: a case report. J Med Case Rep. 2019;13:27. doi: 10.1186/s13256-018-1929-z
6. Gur S, Taler M, Bormant G, Blattberg D, Nitzan U, Vaknin-Dembinsky A, et al. Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies. Brain Behav Immun. 2020;88:930–4. doi: 10.1016/j.bbi.2020.05.001
7. Landén M, Jonsson L, Klahn AL, Kardell M, Göteson A, Abé C, et al. The St. Göran Project: A Multipronged Strategy for Longitudinal Studies for Bipolar Disorders. Neuropsychobiology. 2025:1–14. doi: 10.1159/000543335
8. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003;53:1028–42. doi: 10.1016/S0006-3223(03)00165-3
9. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33. doi: 10.1037/t18597-000
10. Mullier F, Bailly N, Chatelain C, Chatelain B, Dogn_e J-M. Pre-analytical issues in the measurement of circulating extracellular vesicles (EVs): current recommendations and pending questions. J Thromb Haemost. 2013;11:693–6. doi: 10.1111/jth.12171
11. Isgren A, Göteson A, Holmén-Larsson J, Pelanis A, Sellgren C, Joas E, et al. Cerebrospinal fluid proteomic study of two bipolar disorder cohorts. Mol Psychiatry. 2022;27(11):4568–74. doi: 10.1038/s41380-022-01724-2
12. Göteson A, Isgren A, Jonsson L, Sparding T, Smedler E, Pelanis A, et al. Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder. Mol Psychiatry. 2021;26(12):7446–53. doi: 10.1038/s41380-021-01236-5
13. Isgren A, Jakobsson J, Pålsson E, Ekman CJ, Johansson AG, Sellgren C, et al. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment. Brain Behav Immun. 2015;43:198–204. doi: 10.1016/j.bbi.2014.10.001
14. Chang WH, Su CC, Chen KC, Hsiao YY, Chen PS, Yang YK. Which severe mental illnesses most increase the risk of developing dementia? Comparing the risk of dementia in patients with schizophrenia, major depressive disorder and bipolar disorder. Clin Psychopharmacol Neurosci. 2023;21(3):478–87. doi: 10.9758/cpn.22.991
15. Zhao NO, Topolski N, Tusconi M, Salarda EM, Busby CW, Lima CNNC, et al. Blood-brain barrier dysfunction in bipolar disorder: molecular mechanisms and clinical implications. Brain Behav Immun Health. 2022;21:100441. doi: 10.1016/j.bbih.2022.100441
16. Furman CS, Gorelick-Feldman DA, Davidson KG, Yasumura T, Neely JD, Agre P, et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A. 2003;100(23):13609–14. doi: 10.1073/pnas.2235843100
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Upsala Medical Society. Read the full Copyright- and Licensing Statement.
